Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 12NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 5CNS 3Breast 2Sarcoma 1Other hematologic neoplasm 1Other 1Lymphoid 1

Conditions

Lymphoma 159Precursor Cell Lymphoblastic Leukemia-Lymphoma 130Leukemia 72Lymphoma, Large B-Cell, Diffuse 61Leukemia, Lymphocytic, Chronic, B-Cell 56Burkitt Lymphoma 56Hodgkin Disease 55Lymphoma, Follicular 48Lymphoma, Non-Hodgkin 43Lymphoma, Mantle-Cell 35Lymphoma, Large-Cell, Anaplastic 32Leukemia, Myeloid, Acute 27Lymphoma, B-Cell, Marginal Zone 25Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 24Lymphoma, Large-Cell, Immunoblastic 24Leukemia, Biphenotypic, Acute 24Waldenstrom Macroglobulinemia 23Recurrence 21Lymphoma, T-Cell, Cutaneous 21Mycosis Fungoides 18Dendritic Cell Sarcoma, Interdigitating 18Sezary Syndrome 16Immunoblastic Lymphadenopathy 14Myelodysplastic Syndromes 13Leukemia, Myelomonocytic, Juvenile 13Leukemia, Myelomonocytic, Chronic 13Central Nervous System Neoplasms 13Myeloproliferative Disorders 12Multiple Myeloma 12Blast Crisis 12

Interventions

Vincristine 1Rituximab 1Procarbazine 1Methotrexate 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Neurotoxicity Syndromes × Lymphoid × Clear all
NCT01399372 2023-07-20

Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Radiation Therapy Oncology Group

Phase 2 Completed
91 enrolled 17 charts
Lymphoid

Lymphoma, Radiation Injuries, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡